Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Net Cash Flow (2016 - 2025)

Biomerica's Net Cash Flow history spans 16 years, with the latest figure at -$509000.0 for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 35.65% year-over-year to -$509000.0; the TTM value through Nov 2025 reached $164000.0, up 103.27%, while the annual FY2025 figure was -$1.8 million, 68.2% up from the prior year.
  • Net Cash Flow for Q4 2025 was -$509000.0 at Biomerica, down from $652000.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $6.4 million in Q2 2023 and bottomed at -$4.2 million in Q2 2022.
  • The 5-year median for Net Cash Flow is -$728500.0 (2024), against an average of -$167180.6.
  • The largest annual shift saw Net Cash Flow soared 833.68% in 2022 before it plummeted 1115.79% in 2023.
  • A 5-year view of Net Cash Flow shows it stood at $2.2 million in 2021, then tumbled by 145.3% to -$1.0 million in 2022, then grew by 14.6% to -$854000.0 in 2023, then grew by 7.38% to -$791000.0 in 2024, then skyrocketed by 35.65% to -$509000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Net Cash Flow are -$509000.0 (Q4 2025), $652000.0 (Q3 2025), and -$666000.0 (Q2 2025).